Biguanide class drugs

8 results

  • invokamet

    (canagliflozin and metformin hydrochloride)
    Janssen Pharmaceuticals, Inc.
    INVOKAMET and INVOKAMET XR are indicated as adjuncts to diet and exercise for improving glycemic control in adults and pediatric patients aged 10 and older with type 2 diabetes mellitus. Canagliflozin component reduces risks of major cardiovascular events and kidney disease in specific patient populations.

  • janumet

    (SITAGLIPTIN and METFORMIN HYDROCHLORIDE)
    Merck Sharp & Dohme LLC
    JANUMET is indicated for improving glycemic control in adults with type 2 diabetes as an adjunct to diet and exercise. It should not be used in type 1 diabetes and has not been studied in patients with a history of pancreatitis.

  • janumet

    (sitagliptin and metformin hydrochloride)
    Merck Sharp & Dohme LLC
    JANUMET XR is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes mellitus. It is not for use in patients with type 1 diabetes or those with a history of pancreatitis.

  • jentadueto

    (linagliptin and metformin hydrochloride)
    Boehringer Ingelheim Pharmaceuticals, Inc.
    JENTADUETO is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is not recommended for patients with type 1 diabetes or a history of pancreatitis, as its effects in these populations are unclear.

  • kombiglyze

    (SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE)
    AstraZeneca Pharmaceuticals LP
    KOMBIGLYZE XR is indicated for the management of type 2 diabetes mellitus in adults. It is not recommended for treating type 1 diabetes mellitus or diabetic ketoacidosis.

  • segluromet

    (ertugliflozin and metformin hydrochloride)
    Merck Sharp & Dohme LLC
    SEGLUROMET® is indicated for improving glycemic control in adults with type 2 diabetes mellitus, as an adjunct to diet and exercise. It is not recommended for use in patients with type 1 diabetes.

  • synjardy

    (empagliflozin and metformin hydrochloride)
    Boehringer Ingelheim Pharmaceuticals, Inc.
    SYNJARDY and SYNJARDY XR are indicated as adjuncts to diet and exercise to improve glycemic control in adults and pediatric patients (≥10 years) with type 2 diabetes mellitus. Empagliflozin also reduces the risk of cardiovascular death and heart failure hospitalization in adults with established cardiovascular disease.

  • trijardy xr

    (empagliflozin, linagliptin, metformin hydrochloride)
    Boehringer Ingelheim Pharmaceuticals, Inc.
    TRIJARDY XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Empagliflozin within the combination helps reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease. Not for type 1 diabetes.